Analyst Ratings for Pfizer
Portfolio Pulse from Benzinga Insights
Pfizer (NYSE:PFE) has received 3 somewhat bullish and 5 indifferent analyst ratings in the last quarter, with an average price target of $50.88, implying an upside from the current price of $38.73. The average price target has increased by 9.66% over the past month.
June 22, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pfizer has 3 somewhat bullish and 5 indifferent analyst ratings, with an average price target of $50.88, implying an upside from the current price of $38.73. The average price target has increased by 9.66% over the past month.
The average price target of $50.88 implies an upside potential for Pfizer's stock, and the increase of 9.66% in the average price target over the past month indicates growing optimism among analysts. This could lead to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100